Paper · 14718374

Interactions of heparin/heparan sulfate with proteins: appraisal of structural factors and experimental approaches.

Powell AK and 3 others. Glycobiology, 2004. Cited by 215 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Interactions of heparin/heparan sulfate with proteins: appraisal of structural factors and experimental approaches. Papers, record 14718374. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14718374

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Interactions of heparin/heparan sulfate with proteins: appraisal of structural factors and experimental approaches.; PubMed
Journal: Glycobiology; PubMed
Year: 2004; PubMed
Publication types: Journal Article, Research Support, Non-U.S. Gov't, Review; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/14718374/; PubMed
DOI: https://doi.org/10.1093/glycob/cwh051; PubMed
The journal: https://conductscience.org/library/journal-index/9104124; PubMed
Citations, by iCite: 215; iCite
Relative citation ratio, by iCite: 5.37; iCite
Revised in PubMed: 2026-01-28; PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Powell AK	Andrew K
2	Yates EA	Edwin A
3	Fernig DG	David G
4	Turnbull JE	Jeremy E

Source PubMed

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Heparin	Major topic
Heparan Sulfate	Major topic
Proteins	Major topic
Carbohydrate Conformation
Protein Conformation
Structure-Activity Relationship

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by92

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 215 citations.

PMID	Title	Journal	Year	In Papers	Source
41,893,212	Heparin-Based Biomaterials for Sustained Release of Growth Factors for Bone Tissue Engineering and Regeneration.	J Funct Biomater	2026	https://conductscience.org/library/papers/41893212	PubMed
39,476,845	Mass Spectrometry Imaging with Trapped Ion Mobility Spectrometry Enables Spatially Resolved Chondroitin, Dermatan, and Hyaluronan Glycosaminoglycan Oligosaccharide Analysis In Situ.	Anal Chem	2024	https://conductscience.org/library/papers/39476845	PubMed
39,185,923	Synthesis of 2-Amino-2-deoxy Sugars via Boron-Catalyzed Coupling of Glycosyl Fluorides and Silyl Ether Acceptors.	Org Lett	2024	https://conductscience.org/library/papers/39185923	PubMed
38,980,938	Unveiling Charge-Pair Salt-Bridge Interaction Between GAGs and Collagen Protein in Cartilage: Atomic Evidence from DNP-Enhanced ssNMR at Natural Isotopic Abundance.	J Am Chem Soc	2024	https://conductscience.org/library/papers/38980938	PubMed
38,818,051	Proline Isomerization and Molten Globular Property of TgPDCD5 Secreted from Toxoplasma gondii Confers Its Regulation of Heparin Sulfate Binding.	JACS Au	2024	https://conductscience.org/library/papers/38818051	PubMed
37,143,369	Pteropine orthoreoviruses use cell surface heparan sulphate as an attachment receptor.	Emerg Microbes Infect	2023	https://conductscience.org/library/papers/37143369	PubMed
35,585,797	Design and Synthesis of 6-O-Phosphorylated Heparan Sulfate Oligosaccharides to Inhibit Amyloid β Aggregation.	Chembiochem	2022	https://conductscience.org/library/papers/35585797	PubMed
34,900,335	Syndecan-4 functionalization of tissue regeneration scaffolds improves interaction with endothelial progenitor cells.	Regen Biomater	2021	https://conductscience.org/library/papers/34900335	PubMed
34,576,979	Isolation and Characterization of Heparan Sulfate from Human Lung Tissues.	Molecules	2021	https://conductscience.org/library/papers/34576979	PubMed
34,094,105	Chemical synthesis of human syndecan-4 glycopeptide bearing O-, N-sulfation and multiple aspartic acids for probing impacts of the glycan chain and the core peptide on biological functions.	Chem Sci	2020	https://conductscience.org/library/papers/34094105	PubMed

1 to 10 of 92

See all 92 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/14718374

GET https://conductscience.org/api/papers/v1/14718374/cited_by?page=2

API reference For AI assistants